HempNewsBreaks – PotNetwork Holding, Inc. (POTN) Leverages Month-Over-Month Sales Growth to Greatly Exceed 2017 Revenue Projections

PotNetwork Holding, Inc. (OTC: POTN) this morning announced that, as a result of the rapid growth in sales of its Diamond CBD, Inc. subsidiary, it achieved revenues of approximately $14.5 million for the 2017 calendar year. Notably, this figure exceeded the company’s earlier projections of $8.3 million by more than 70 percent. “2017 has been a phenomenally successful year for us! Our unprecedented sales growth pays tribute to the hard work of our staff and our resellers, and the exceptional quality of our CBD product line which expanded greatly over 2017,” Richard Goulding, CEO of PotNetwork, stated in the news release. “We are poised to continue 2017’s growth during 2018 as we embark on new and unique marketing initiatives and embrace new opportunities with the potential of providing strong returns on investment for our shareholders.” Paying tribute to this performance, as well as the company’s future prospects, PotNetwork was recently named ‘One of Five Notable CBD Revolution Industry Leaders’ in an article published by The Huffington Post.

To view the full press release, visit http://cnw.fm/Qzh10

About PotNetwork Holding, Inc.

PotNetwork Holding, Inc. (OTC Pink: POTN) is a publicly traded company that acts as a holding company for its subsidiaries, First Capital Venture Co., the owner of Diamond CBD, Inc., the maker of Diamond CBD oils. For more information, visit the company’s website at www.PotNetworkHolding.com

More from CannabisNewsBreaks

About HempWire

HempWire (HW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) HempNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, HW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. HW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, HW brings its clients unparalleled visibility, recognition and brand awareness. HW is where news, content and information converge.

For more information please visit https://www.hempwire.com

Please see full terms of use and disclaimers on the HempWire website applicable to all content provided by HW, wherever published or re-published: https://www.hempwire.com/disclaimer/

HempWire (HW)
Denver, Colorado
www.hempwire.com
303.498.7722 Office
Editor@HempWire.net

Chris@HW

Share
Published by
Chris@HW

Recent Posts

HempNewsBreaks – Turning Point Brands Inc. (NYSE: TPB) Closes $300M Senior Secured Notes Offering 

Turning Point Brands (NYSE: TPB), a manufacturer, marketer and distributor of branded consumer products, recently…

2 months ago

HempNewsBreaks – WEED Inc. (BUDZ) Announces 2024 Highlights, Plans to Expand into Consumer Packaged Goods

WEED Inc. (OTCQB: BUDZ), a global cannabis and hemp bioresearch company based in the U.S.,…

4 months ago

HempNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Closes $3.6M Registered Direct

Flora (NASDAQ: FLGC) has closed a registered direct offering to institutional investors for the aggregate…

5 months ago

HempNewsBreaks – Golden Triangle Ventures Inc. (GTVH) to Host Spaces Event, Share Comprehensive Update on Destino Ranch

Golden Triangle Ventures (OTC: GTVH) (“GTV”) today announced its plans to host a Spaces call…

5 months ago

HempNewsBreaks – CBD Life Sciences Inc. (CBDL) Poised to Become Game Changer in the Hemp Industry

CBD Life Sciences (OTC: CBDL) today announced its potential for explosive profits in a $70…

6 months ago

HempNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Cleared to Begin Human Pilot Study #3 Evaluating DehydraTECH-Processed Tirzepatide

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, announced Friday that…

7 months ago